Head of Tech. & Innovation, Pharmacometrics & Systems Pharmacology Pfizer, United States
Disclosure(s):
Timothy Nicholas, PhD: No relevant disclosure to display
This talk will provide a thorough description of the model-informed drug development (MIDD) paradigm and the concept of model development lifecycle (MDLC). Dr Nicholas will highlight how the MMF can be utilized to document a fit-for-purpose model supporting interpretations and decisions for medicines and novel formulations.
